Costs Gulp 46% Of Neimeth’s Turnover As Expenses Rise By 296%
Over N1.20 billion was recorded as revenue by Neimeth International Pharmaceuticals Plc in the first quarter (Q1) of 2025, exceeding the N648.25 million turnover reported in Q1 2024, reflecting an increase of 86 percent. However, the cost of sales increased threefold or
Follow Us